JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
Yext
YEXT
$574M
| $438K | ﹤0.01% |
30,402
-73
| -0.2% | -$1.13K |
|
|
RCM
4127
DELISTED
R1 RCM Inc. Common Stock
RCM
| $438K | ﹤0.01% |
33,708
-322
| -0.9% | -$3.68K |
|
4128
Axogen
AXGN
$2.67B
| $437K | ﹤0.01% |
24,460
+11,025
| +82% | +$163K |
|
4129
ANI Pharmaceuticals
ANIP
$1.73B
| $436K | ﹤0.01% |
7,077
-64,348
| -90% | -$4.26M |
|
|
SMMF
4130
DELISTED
Summit Financial Group, Inc.
SMMF
| $436K | ﹤0.01% |
16,083
+9,509
| +145% | +$251K |
|
|
MDR
4131
CALL
DELISTED
McDermott International
MDR
| $435K | ﹤0.01% |
642,600
-5,323,600
| -89% | -$6.8M |
|
4132
CorVel
CRVL
$3.17B
| $434K | ﹤0.01% |
14,898
+3,090
| +26% | +$82.2K |
|
|
ACOR
4133
DELISTED
Acorda Therapeutics
ACOR
| $434K | ﹤0.01% |
1,773
-112
| -6% | -$28.3K |
|
|
LJPC
4134
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $434K | ﹤0.01% |
110,240
-9,850
| -8% | -$58.2K |
|
|
YELL
4135
CALL
DELISTED
Yellow Corporation Common Stock
YELL
| $433K | ﹤0.01% |
169,900
+150,000
| +754% | +$515K |
|
4136
Princeton Bancorp
BPRN
$295M
| $432K | ﹤0.01% |
13,714
+5,473
| +66% | +$161K |
|
|
GNTY
4137
DELISTED
Guaranty Bancshares
GNTY
| $432K | ﹤0.01% |
14,417
+11,485
| +392% | +$335K |
|
|
AGS
4138
DELISTED
PlayAGS
AGS
| $430K | ﹤0.01% |
35,450
+26,727
| +306% | +$305K |
|
|
GFN
4139
DELISTED
General Finance Corporation
GFN
| $430K | ﹤0.01% |
38,819
+572
| +1% | +$5.64K |
|
|
VAPO
4140
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $429K | ﹤0.01% |
4,417
-3,624
| -45% | -$306K |
|
|
TBIO
4141
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $429K | ﹤0.01% |
52,637
+41,818
| +387% | +$386K |
|
4142
Natural Health Trends
NHTC
$15.4M
| $424K | ﹤0.01% |
78,876
+2,354
| +3% | +$15.1K |
|
4143
Granite Construction
GVA
$5.52B
| $423K | ﹤0.01% |
15,291
-43,864
| -74% | -$1.25M |
|
|
PVBC
4144
DELISTED
Provident Bancorp
PVBC
| $422K | ﹤0.01% |
33,879
+31,054
| +1,099% | +$366K |
|
4145
First Bancorp
FNLC
$402M
| $421K | ﹤0.01% |
13,908
+10,312
| +287% | +$293K |
|
4146
Peloton Interactive
PTON
$2.38B
| $421K | ﹤0.01% |
14,845
-36,255
| -71% | -$977K |
|
4147
Greif Class B
GEF.B
$4.24B
| $419K | ﹤0.01% |
8,104
+6,128
| +310% | +$304K |
|
4148
Chord Energy
CHRD
$7.53B
| $417K | ﹤0.01% |
128,346
-8,147,668
| -98% | -$23.3M |
|
4149
CALL
Ichor Holdings
ICHR
$2.59B
| $416K | ﹤0.01% |
+12,500
| New | +$373K |
|
4150
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.41B
| $415K | ﹤0.01% |
6,393
-499
| -7% | -$31K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.